Drug Price Transparency

Jul 16, 2018
AHA comments on the 340B section of the Department of Health and Human Services’ Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs.
Jul 12, 2018
AHA commends MedPAC and HHS for voicing significant concerns about rising pharmaceutical costs. 
Jun 7, 2018
June 7, 2018
The American Hospital Association and others support Senators Grassley and Feinstein of the Senate Judiciary Committee for their leadership and commitment to reducing out-of-control prescription drug prices and stopping anti-competitive abuses that keep drug prices high. Read the full letter below…
May 22, 2018
AHA comments to HRSA regarding proposed rule that would further delay the effective date for implementing final regulations regarding the 340B Drug Pricing Program ceiling price and drug manufacturers’ civil monetary penalties (CMPs) for violations of the ceiling price.
May 18, 2018
Medicare Part D prescription drug plans should not prevent pharmacies from telling customers when they could pay less for a drug by paying cash, the Centers for Medicare & Medicaid Services told plan sponsors yesterday. “An important step in putting patients first and lowering out-of-pocket…
May 17, 2018
The Food and Drug Administration today announced new efforts to spotlight situations where drugmakers may be pursuing “gaming tactics” to delay generic competition. “Today, we’re making public a list of companies that have potentially been blocking access to the samples of their branded products,”…
May 15, 2018
The Centers for Medicare & Medicaid Services today updated the Parts B and D drug spending dashboards with 2016 information. The dashboards provide pricing and utilization information for drugs covered under Medicare Parts B and D, including the total amount the program spent on a covered drug…
Mar 26, 2018
The AHA Friday submitted comments to Sens. Bill Cassidy (R-LA), Michael Bennet (D-CO), Chuck Grassley (R-IA), Tom Carper (D-DE), Todd Young (R-IN) and Claire McCaskill (D-MO) as they develop legislation to improve price transparency in the health care market and lower costs. The senators last month…
Mar 8, 2018
The Campaign for Sustainable Rx Pricing, of which the AHA is a founding member, today released a digital and television ad urging Congress to pass the Creating and Restoring Equal Access to Equivalent Samples Act to lower drug prices. The ad is running on CNN and Fox in Washington, DC, and on…
Mar 1, 2018
Sens. Bill Cassidy (R-LA), Michael Bennet (D-CO), Chuck Grassley (R-IA), Tom Carper (D-DE), Todd Young (R-IN) and Claire McCaskill (D-MO) are seeking guidance from health care stakeholders as they develop legislation to improve price transparency in the health care market and lower costs. In a…